Description
Identification of therapeutically relevant gene mutations for Cancer
NTRK PANEL BY NGS
Identification of therapeutically relevant gene mutations for Cancer
TAT:
Specimen Type:
Genomics Panel Test
Other Tests
-
264%
OncQuer TM Scout LB KRAS Mutation Test
Identification gene mutations leading to resistance to EGFR therapy
OncQuer TM Scout LB KRAS Mutation Test
Identification gene mutations leading to resistance to EGFR therapy
-
264%
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
264%
OncQuer TM Scout LB EGFR Sensitivity Test
Identification gene mutations leading to sensitivity to EGFR therapy
OncQuer TM Scout LB EGFR Sensitivity Test
Identification gene mutations leading to sensitivity to EGFR therapy
- 263%
Reviews
There are no reviews yet.